Clinical trial
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and…
NCT00185640 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00185640 |
|---|---|
| Title | Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies |
| Official title | Allogeneic Hematopoietic Cell Transplantation Using a Non-Myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin for Older Patients With Hematologic Malignancies |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Blood Cancer, Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | Cyclosporine, Anti-thymocyte globulin (ATG), Mycophenolate mofetil (MMF), Filgrastim, Total Lymphoid Irradiation (TLI) |
| Enrollment | 303 |
| Start date | Mar 1, 2003 |
| Primary completion | Apr 1, 2014 |
| Completion | Jan 1, 2016 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 29, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: